Olaparib trials for Prostate cancer

All Olaparib trials · All Prostate cancer trials

Phase breakdown

Recruiting trials studying Olaparib for Prostate cancer

• A Phase 1 Study of XL309 (ISM3091) Alone and in Combination in Participants With Advanced Solid Tumors
  NCT05932862 · Phase: Phase 1 · Ages: 18 Years and older · Sex: All (male and female) · 32 locations
• Carboplatin or Olaparib for BRcA Deficient Prostate Cancer
  NCT04038502 · Phase: Phase 2 · Ages: 18 Years and older · Sex: Male · 18 locations
• Pembro With Radiation With or Without Olaparib
  NCT05568550 · Phase: Phase 2 · Ages: 18 Years and older · Sex: Male · 2 locations
• Study of Orally Administered MOMA-313 in Participants With Advanced or Metastatic Solid Tumors
  NCT06545942 · Phase: Phase 1 · Ages: 18 Years and older · Sex: All (male and female) · 36 locations
• Substudy 01A: Safety and Efficacy of Opevesostat (MK-5684)-Based Treatment Combinations or Opevesostat Alone in Participants With Metastatic Castration-resistant Prostate Cancer (mCRPC) (MK-5684-01A)
  NCT06353386 · Phase: Phase 1, Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 77 locations

Common questions

How many trials study Olaparib for Prostate cancer?

5 recruiting trials.

Is this list complete?

No. For the full record, search ClinicalTrials.gov.